Summary
NHS access to the drug, which costs over 500,000 per patient per year, had been due to expire at the end of May, however an agreement was reached allowing existing patients to continue to have it.
Source: BBC
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
